C. Tyson

发表

W. L. Nourse, C. Tyson, R. Bednarz, 1995, Toxicology in vitro : an international journal published in association with BIBRA.

cDNA cloning and inducible expression of human multidrug resistance associated protein 3 (MRP3).

Y. Sugiyama, C. Tyson, H. Suzuki, 1998, FEBS letters.

Oxidative DNA damage induced by potassium bromate in isolated rat renal proximal tubules and renal nuclei.

C. Tyson, R. Hasegawa, Y. Kurokawa, 1994, Cancer letters.

In Vitro Screens From Cns, Liver and Kidney for Systemic Toxicity

C. Tyson, N. Stacey, 1989, Toxicology and industrial health.

P-450 cam hydroxylase: substrate-effector and electron-transport reactions.

J. Lipscomb, C. Tyson, R. Tsai, 1971, Chemico-biological interactions.

Primary active transport of organic anions on bile canalicular membrane in humans.

Y. Sugiyama, Y. Kato, C. Tyson, 1999, American journal of physiology. Gastrointestinal and liver physiology.

In Vitro/in Vivo scaling of alprazolam metabolism by CYP3A4 and CYP3A5 in humans

Y. Sugiyama, Kiyomi Ito, C. Tyson, 2001, Biopharmaceutics & drug disposition.

Primary active transport of organic anions on bile canalicular membrane in humans.

Y. Sugiyama, Y. Kato, C. Tyson, 1999, The American journal of physiology.

Potential cholestatic activity of various therapeutic agents assessed by bile canalicular membrane vesicles isolated from rats and humans.

Y. Sugiyama, Y. Kato, C. Tyson, 2003, Drug metabolism and pharmacokinetics.

4-Nitrocatechol as a colorimetric probe for non-heme iron dioxygenases.

C. Tyson, 1975, The Journal of biological chemistry.

Mechanism of uncoupling in mitochondria: uncouplers as ionophores for cycling cations and protons.

C. Tyson, D. E. Green, R. Kessler, 1976, Proceedings of the National Academy of Sciences of the United States of America.

6 – Cytotoxicity Measures: Choices and Methods

C. Tyson, C. Green, 1987 .

The role of putidaredoxin and P450 cam in methylene hydroxylation.

J. Lipscomb, C. Tyson, I. C. Gunsalus, 1972, The Journal of biological chemistry.

Cyanide-induced cytotoxicity to isolated hepatocytes.

C. Tyson, S. Gee, C. Green, 1990, Toxicology in vitro : an international journal published in association with BIBRA.

Methods in Toxicology

C. Tyson, H. Witschi, 2018, Toxicology and Risk Assessment.

Metabolism and cytotoxicity of acetaminophen in hepatocytes isolated from resistant and susceptible species.

C. Tyson, C. Green, J. Dabbs, 1984, Toxicology and applied pharmacology.

Toxicity of dolastatin 10 in mice, rats and dogs and its clinical relevance

C. Tyson, J. Tomaszewski, S. J. Donohue, 1999, Cancer Chemotherapy and Pharmacology.

Functional integrity of isolated rat hepatocytes prepared by whole liver vs biopsy perfusion.

C. Tyson, C. Green, J. Dabbs, 1983, Analytical biochemistry.

Synergistic bone marrow toxicity of pyrimethamine and zidovudine in murine in vivo and in vitro models: mechanism of toxicity.

J. T. Macgregor, C. Tyson, J. Dabbs, 2002, Toxicology and applied pharmacology.

Extended rat liver slice survival and stability monitored using clinical biomarkers.

A. Vickers, C. Tyson, H. Behrsing, 2003, Biochemical and biophysical research communications.

Variation of Hepatic Methotrexate 7‐Hydroxylase Activity in Animals and Humans

S. Kitamura, S. Ohta, C. Tyson, 1999, IUBMB life.

In vitro detection of differential and cell-specific hepatobiliary toxicity induced by geldanamycin and 17-allylaminogeldanamycin in rats.

C. Tyson, K. Amin, H. Behrsing, 2005, Toxicology in vitro : an international journal published in association with BIBRA.

Differences in Rat Liver Enzyme-Altered Foci Produced By Chlorinated Aliphatics and Phenobarbital

C. Tyson, H. Milman, E. Meierhenry, 1986, Toxicology and industrial health.

Interspecies comparisons of skin irritancy.

C. Tyson, G. Nixon, W. C. Wertz, 1975, Toxicology and applied pharmacology.

Comparison of amphetamine metabolism using isolated hepatocytes from five species including human.

C. Tyson, C. Green, S. LeValley, 1986, The Journal of pharmacology and experimental therapeutics.

Kinetics and mechanism of the metal chelate catalyzed oxidation of pyrocatechols.

C. Tyson, A. Martell, 1972, Journal of the American Chemical Society.

Kinetic studies on the autoxidation of 3,5-di-tert-butylpyrocatechol

C. Tyson, A. Martell, 1970 .

Equilibriums of metal ions with pyrocatechol and 3,5-di-tert-butylpyrocatechol

C. Tyson, A. Martell, 1968 .

Application of a hepatocyte-erythrocyte coincubation system to studies of cyanide antidotal mechanisms.

C. Tyson, S. Gee, S. LeValley, 1987, Toxicology and applied pharmacology.

Mechanism of Chemical Action and Treatment of Cyanide Poisoning

C. Tyson, 1986 .

Response of isolated hepatocytes to organic and inorganic cytotoxins.

D L Story, C. Tyson, S. Gee, 1983, Journal of toxicology and environmental health.

Correspondence of Results From Hepatocyte Studies With in Vivo Response

C. Tyson, 1987, Toxicology and industrial health.

Short-term oral toxicity of a 2,4,6-trinitrotoluene and hexahydro-1,3,5-trinitro-1,3,5-triazine mixture in mice, rats, and dogs.

C. Tyson, G. Newell, J. Dacre, 1982, Journal of toxicology and environmental health.

Electron spin resonance in tert-butyl-substituted semiquinones. The hyperfine structure of tert-butyl protons

C. Tyson, G. Giacometti, C. Trapp, 1968 .

Phospholipids as ionophores.

C. Tyson, D. E. Green, H. V. Vande Zande, 1976, The Journal of biological chemistry.

Potential use of human tissues for toxicity research and testing.

L. Ducat, G. Powis, C. Tyson, 1989, Toxicology and applied pharmacology.

Ultrastructural changes in isolated rat hepatocytes exposed to different CCl4 concentrations.

R. J. Stephens, C. Tyson, D. Story, 1983, Biochemical and biophysical research communications.

Evaluation of hepatocytes isolated by a nonperfusion technique in a prescreen for cytotoxicity.

C. Tyson, C. Mitoma, C A Tyson, 1980, Journal of toxicology and environmental health.

Short-term oral toxicity of 2,4,6-trinitrotoluene in mice, rats, and dogs.

C. Tyson, G. Newell, J. Dacre, 1982, Journal of toxicology and environmental health.

Overview of Approaches to In Vitro Neurotoxicity Testing

M. Halks-Miller, C. Tyson, Veronica Fedor, 1991 .

Prediction of in vivo drug metabolism in the human liver from in vitro metabolism data.

T Ishizaki, K Chiba, Y. Sugiyama, 1997, Pharmacology & therapeutics.

The potential for an interaction between MRP2 (ABCC2) and various therapeutic agents: probenecid as a candidate inhibitor of the biliary excretion of irinotecan metabolites.

Y. Sugiyama, Y. Kato, C. Tyson, 2002, Drug metabolism and pharmacokinetics.

Mammalian Toxicological Evaluation of TNT Wastewaters. Volume II. Acute and Subacute Mammalian Toxicity of TNT and LAP Mixture

C. Tyson, G. Newell, J. Dilley, 1979 .

Uncouplers and the molecular mechanism of uncoupling in mitochondria.

C. Tyson, D. E. Green, G. Blondin, 1977, Proceedings of the National Academy of Sciences of the United States of America.

An In Vitro Cytotoxicity Assay Using Rat Hepatocytes and MTT and Coomassie Blue Dye as Indicators

C. Tyson, K. Komiyama, K. Otoguro, 1991 .

Prediction of in vivo drug-drug interactions between tolbutamide and various sulfonamides in humans based on in vitro experiments.

Y. Sugiyama, S. Imaoka, C. Tyson, 2000, Drug metabolism and disposition: the biological fate of chemicals.

Influence of prior freezing on arylamine acetylation by human liver preparations.

C. Tyson, C. Green, J. Peters, 1994, Toxicology in Vitro.

Vaccination with a recombinant vaccinia vaccine containing the B7‐1 co‐stimulatory molecule causes no significant toxicity and enhances T cell–mediated cytotoxicity

J. Schlom, C. Tyson, J. Kantor, 2000, International journal of cancer.

Polymorphic N-acetylation of sulfamethazine and benzidine by human liver: implication for cancer risk?

C. Tyson, C. Green, J. Peters, 1990, Anticancer research.

cDNA cloning and inducible expression of human multidrug resistance associated protein 3 (MRP3) 1

Y. Sugiyama, C. Tyson, T. Hirohashi, 1998 .

Biliary excretion mechanism of CPT-11 and its metabolites in humans: involvement of primary active transporters.

Y. Sugiyama, X. Chu, Y. Kato, 1998, Cancer research.

In vitro human tissue models in risk assessment: report of a consensus-building workshop.

J B Houston, G. L. Kedderis, K Krishnan, 2001, Toxicological sciences : an official journal of the Society of Toxicology.

Prediction of in vivo hepatic metabolic clearance of YM796 from in vitro data by use of human liver microsomes and recombinant P-450 isozymes.

Y. Sugiyama, T. Kamataki, C. Tyson, 1997, The Journal of pharmacology and experimental therapeutics.

Subchronic inhalation toxicity of 1,3,5-trichlorobenzene.

C. Tyson, C. Mitoma, J. Johnson, 1983, Drug and chemical toxicology.

Characterization of ANIT-Induced Toxicity using Precision-Cut Rat and Dog Liver Slices Cultured in a Dynamic Organ Roller System

C. Tyson, K. Amin, C. Green, 2006, Toxicologic pathology.

Analogy Models for Prediction of Human Toxicity

Svante Wold, Lennart Eriksson, Sven Hellberg, 1990 .

Toxicity of a quinocarmycin analog, DX-52-1, in rats and dogs in relation to clinical outcome

C. Tyson, C. Mitoma, C. Green, 2003, Cancer Chemotherapy and Pharmacology.

Regulation of differentiated phenotype of rat hepatic lipocytes by retinoids in primary culture.

C. Tyson, R. Kato, T. Sato, 1995, Experimental cell research.

Stress initiated during isolation of rat renal proximal tubules limits in vitro survival.

C. Tyson, C. Green, E. Rauckman, 1990, Renal failure.

Correlations of in vitro and in vivo hepatotoxicity for five haloalkanes.

C. Tyson, D. Gould, D. H. Gould, 1983, Toxicology and applied pharmacology.

Rat Liver Foci and in Vitro Assays to Detect Initiating and Promoting Effects of Chlorinated Ethanes and Ethylenes a

C. Tyson, H. Milman, E. Riccio, 1988, Annals of the New York Academy of Sciences.

Prediction of In Vivo Interaction Between Triazolam and Erythromycin Based on In Vitro Studies Using Human Liver Microsomes and Recombinant Human CYP3A4

Y. Sugiyama, Kiyomi Ito, C. Tyson, 2000, Pharmaceutical Research.

In vitro detection of differential and cell-specific hepatobiliary toxicity induced by geldanamycin and 17-allylaminogeldanamycin using dog liver slices.

C. Tyson, K. Amin, H. Behrsing, 2005, Toxicological sciences : an official journal of the Society of Toxicology.

Comparative metabolism of tolbutamide by isolated hepatocytes from rat, rabbit, dog, and squirrel monkey.

C. Tyson, S. Gee, C. Green, 1984, Drug metabolism and disposition: the biological fate of chemicals.

In vitro toxicity indicators

C. Tyson, J. Frazier, 1994 .

R. J. Stephens, K. Lunan, C. Tyson, 1982, Archives of environmental health.

Influence of acetaldehyde and ethanol on rat hepatic lipocyte characteristics in primary culture

R. Kato, C. Tyson, N. Murayama, 1995, Cell biology international.

Trichloroethylene biotransformation in human and rat primary hepatocytes.

C. Tyson, C. Green, S. Short, 1990, Toxicology in vitro : an international journal published in association with BIBRA.

Selective binding of acetaminophen (APAP) to liver proteins in mice and men.

Steven D. Cohen, R. Birge, C. Tyson, 1991, Advances in experimental medicine and biology.

Bioactivation of tegafur to 5-fluorouracil is catalyzed by cytochrome P-450 2A6 in human liver microsomes in vitro.

K Chiba, C. Tyson, Kaoru Kobayashi, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Variation of Hepatic Methotrexate 7‐Hydroxylase Activity in Animals and Humans

S. Kitamura, S. Ohta, C. Tyson, 1999, IUBMB life.

Characterization of Isolated Renal Proximal Tubules for Nephrotoxicity Studies

C. Tyson, C. Green, E. Rauckman, 1989 .

Cytotoxicity measures choices and methods

C. Tyson, C. Green, 1987 .